You are here: Industry Insights > Moderna

News List

Vaxart’s Covid-19 vaccine shows cross-coronavirus activity in trial pharmaceutical-technology
May 06, 2021
Vaxart has reported the latest data from the Phase I trial of its first Covid-19 oral vaccine construct, VXA-CoV2-1, which showed broad cross-reactivity against other coronaviruses.
Moderna to supply Covid-19 vaccine doses to Gavi pharmaceutical-technology
May 06, 2021
Moderna has entered an agreement with Gavi, the Vaccine Alliance, to deliver up to 500 million doses of its mRNA Covid-19 vaccine to help low- and middle-income countries fight the pandemic.
Moderna to Increase Global Supply for COVID-19 Vaccine contractpharma
May 06, 2021
Moderna has unveiled plans for new funding commitments to increase supply at its owned and partnered manufacturing facilities, which it expects will increase global 2022 capacity to up to 3 billion doses of its COVID-19 vaccine, depending upon the ...
US senators write to Pfizer, Moderna, J&J for global access to vaccines expresspharma
April 30, 2021
According to the letter, there are several steps that vaccine companies could take to expand access to the vaccines globally, including in India.
Lonza Doubles Drug Substance Production for Moderna’s COVID-19 Vaccine contractpharma
April 30, 2021
Lonza has expanded its collaboration with Moderna to manufacture the drug substance for the biopharma’s COVID-19 vaccine.
DNA Script Partners with Moderna to Develop On-Demand Vaccines and Therapeutics for DARPA americanpharmaceuticalreview
April 28, 2021
DNA Script has announced a partnership with Moderna, Inc. to develop a prototype for rapid mobile manufacturing of vaccines and therapeutics as part of the Defense Advanced Research Projects Agency's (DARPA) Nucleic Acids On-Demand World-Wide (NOW) ...
Sanofi to manufacture Moderna’s Covid-19 vaccine in the US pharmaceutical-technology
April 28, 2021
Sanofi has entered an agreement to manufacture up to 200 million doses of Moderna’s Covid-19 vaccine in the US.
Moderna and Israel sign new Covid-19 vaccine supply agreement pharmaceutical-technology
April 22, 2021
Moderna has signed a new supply agreement with Israel to provide its doses of Covid-19 vaccine candidates next year.
Oxford University expands Com-COV2 dose-mixing study with Novavax’s Covid-19 vaccine pharmaceutical-technology
April 16, 2021
The University of Oxford has expanded the Comparing Covid-19 Vaccine Schedule Combinations – Stage 2 (Com-COV2) study to include the Novavax and Moderna vaccines for the disease treatment.
UK trial evaluating ‘mix and match’ COVID-19 vaccine regimens expanded pharmatimes
April 15, 2021
A UK trial evaluating the safety of mixing different COVID-19 vaccines is set to be expanded to include Moderna and Novavax’s respective jabs.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 22 23 Next page